Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Expression Profiling Provides an Improved Characterization of CD79B-Mutated Diffuse Large B-Cell Lymphomas. | J Pers Med | 2025 | 41295250 | PubTator, text mining | PubMed |
| [A multicenter retrospective study on the clinicopathological features, genetic variant profiles and prognosis of patients with previously untreated Diffuse large B-cell lymphoma]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 41230584 | PubTator, text mining | PubMed |
Acalabrutinib May Offer a New Therapeutic Approach for Consolidation and Maintenance of Primary CNS Lymphoma with Expression of MYD88 and CD79B Gene Variants: A Case Report and Literature Review of Primary CNS Lymphoma in the BTKi Era. | Int J Mol Sci | 2025 | 41226558 | PubTator, text mining | PubMed |
| Chemotherapy-Free Salvage Therapy with Rituximab, Lenalidomide, and Poseltinib in Relapsed or Refractory Primary Central Nervous System Lymphoma: A Multi-Center, Phase II Study. | Cancer Res Treat | 2025 | 41223495 | PubTator, text mining | PubMed |
| Exploring CD19-targeted Immunotherapy Strategies for Human B-cell Lymphoma. | Arch Razi Inst | 2025 | 41179632 | PubTator, text mining | PubMed |
| Exploring molecular characteristics and interactions of blood stasis syndrome in ischemic heart failure by integrated multi-omics. | Front Mol Biosci | 2025 | 41158877 | PubTator, text mining | PubMed |
| Interplay of the Mass Transport and Reaction Kinetics for Lateral Flow Immunoassay Integrated on Lab-on-Disc. | Sensors (Basel) | 2025 | 41157339 | PubTator, text mining | PubMed |
| Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma Preclinical Models. | EJHaem | 2025 | 41140808 | PubTator, text mining | PubMed |
| Chemotherapeutic Drug-Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions. | Curr Oncol Rep | 2025 | 41123838 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma in the new era: prognostic tools for mapping risk. | Ann Hematol | 2025 | 41114812 | PubTator, text mining | PubMed |
| Endoscopic management of intragastric balloon related gastric outlet obstruction: A case report and review of literature. | World J Clin Cases | 2025 | 41113070 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing and Mendelian randomization, revealing molecular mechanisms and causal correlation of immune-related genes in periodontitis. | Sci Rep | 2025 | 41083787 | PubTator, text mining | PubMed |
| First-line treatment with polatuzumab vedotin improves efficacy and survival in newly diagnosed patients with advanced diffuse large B-cell lymphoma: a multicentre retrospective analysis. | Ann Med | 2025 | 41069185 | PubTator, text mining | PubMed |
| Zanubrutinib plus salvage chemotherapy in patients with refractory/relapsed diffuse large B-cell lymphoma non-candidate for autologous stem cell transplantation: A retrospective study. | Ann Hematol | 2025 | 41065812 | PubTator, text mining | PubMed |
| Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration. | Blood Adv | 2025 | 41061156 | PubTator, text mining | PubMed |
| Multi-omic underpinnings of heterogeneous aging across multiple organ systems. | Cell Genom | 2025 | 41043431 | PubTator, text mining | PubMed |
| Integrative Analysis of TLS-Associated Gene Signatures, Immune Infiltration and Drug Sensitivity in Pancreatic Cancer. | IET Syst Biol | 2025 | 41016829 | PubTator, text mining | PubMed |
| Integrating Machine Learning and Multi-Omics to Explore Neutrophil Heterogeneity. | Biomedicines | 2025 | 41007733 | PubTator, text mining | PubMed |
| A Transformer-Based Deep Diffusion Model for Bulk RNA-Seq Deconvolution. | Biology (Basel) | 2025 | 41007295 | PubTator, text mining | PubMed |
| Re-emergence of circulating non-malignant B cells as a prognostic biomarker in chronic lymphocytic leukaemia. | Sci Rep | 2025 | 41006384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=7